ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY (GBM) - ANVISA Registration 80213250377
Access comprehensive regulatory information for ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY (GBM) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80213250377 and manufactured by VIRO-IMMUN LABOR DIAGNOSTIKA GMBH. The registration is held by PHAREBEE DIAGNOSTICOS COMERCIO IMPORTACAO E EXPORTACAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, DR. FOOKE LABORATORIEN GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80213250377
25351391233200941
64128853000196
Company Information
Dates and Status
Nov 30, 2009
VIGENTE
09/18/2025 19:00:01
ANTICORPO ANTIMEMBRANA BASAL GLOMERULAR (GMB)
FAMILIA IFLASH- GBM IGG E GBM IGG CONTROL
SHENZHEN YHLO BIOTECH CO., LTD.
80867150107
Jul 15, 2021
ANTICORPO ANTIMEMBRANA BASAL GLOMERULAR (GMB)
EliA GBM Well
PHADIA AB
80254180386
May 06, 2021
ANTICORPO ANTIMEMBRANA BASAL GLOMERULAR (GMB)
Famรญlia QUANTA Flash GBM
INOVA DIAGNOSTICS, INC.
80003610582
Aug 31, 2020
ANTICORPO ANTIMEMBRANA BASAL GLOMERULAR (GMB)
AI-LFA GBM
DR. FOOKE LABORATORIEN GMBH
10300390827
Jul 08, 2019
ANTICORPO ANTIMEMBRANA BASAL GLOMERULAR (GMB)
Anti-GBM
ORGENTEC DIAGNOSTIKA GMBH
10300390672
May 20, 2019

